Derya Ozturk-Engin1, Canan Agalar2, Yasemin Cag3, Fatma Kesmez Can4, Ilker Inanc Balkan5, Oguz Karabay6, Seniha Senbayrak7, Busra Meral Çetinkaya2, Mehmet Timuçin Aydın8, Kadir Tomas9, Esra Disci10, Ali Surmelioglu11, Orhan Alimoglu12, Ozgur Ekinci12, Emrah Akın13, Mehmet Köroglu14, Mehmet Velidedeoglu15, Handan Ankaralı16, Esra Kocoglu17, Mirkhaliq Javadov18, Berrin Papilla-Kundaktepe15, Naz Oguzoglu19, Erkan Ozmen20, Ramazan Donmez18, Ertunç Mega21, Sebahat Aksaray19, Fatih Agalar18. 1. Department of Infectious Diseases and Clinical Microbiology, Health Sciences University, Fatih Sultan Mehmet Training and Research Hospital, Atasehir, Istanbul, Turkey. derya.ozturkengin@sbu.edu.tr. 2. Department of Infectious Diseases and Clinical Microbiology, Health Sciences University, Fatih Sultan Mehmet Training and Research Hospital, Atasehir, Istanbul, Turkey. 3. Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Istanbul Medeniyet University, Göztepe Training and Research Hospital, Kadikoy, Istanbul, Turkey. 4. Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ataturk University, Yakutiye, Erzurum, Turkey. 5. Department of Infectious Diseases and Clinical Microbiology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Fatih, Istanbul, Turkey. 6. Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Sakarya University, Serdivan, Sakarya, Turkey. 7. Department of Infectious Diseases and Clinical Microbiology, Health Sciences University, Haydarpasa Numune Training and Research Hospital, Uskudar, Istanbul, Turkey. 8. Department of General Surgery, Health Sciences University, Fatih Sultan Mehmet Training and Research Hospital, Atasehir, Istanbul, Turkey. 9. Department of General Surgery. Recep, Faculty of Medicine, Tayyip Erdogan University, Rize, Turkey. 10. Department of General Surgery, Faculty of Medicine, Ataturk University, Yakutiye, Erzurum, Turkey. 11. Department of General Surgery, Health Sciences University, Haydarpasa Numune Training and Research Hospital, Uskudar, Istanbul, Turkey. 12. Department of General Surgery, Faculty of Medicine, Istanbul Medeniyet University, Göztepe Training and Research Hospital, Kadikoy, Istanbul, Turkey. 13. Department of General Surgery, Faculty of Medicine, Sakarya University, Serdivan/Sakarya, Turkey. 14. Department of Medical Microbiology, Faculty of Medicine Serdivan/Sakarya, Sakarya University, Serdivan/Sakarya, Turkey. 15. Department of General Surgery, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Fatih, Istanbul, Turkey. 16. Department of Biostatistics, Faculty of Medicine, Istanbul Medeniyet University, Göztepe Training and Research Hospital, Kadikoy, Istanbul, Turkey. 17. Department of Medical Microbiology, Faculty of Medicine, Istanbul Medeniyet University, Göztepe Training and Research Hospital, Istanbul, Turkey. 18. Department of General Surgery, Faculty of Medicine, Yeditepe University, Istanbul, Turkey. 19. Department of Medical Microbiology, Health Sciences University, Haydarpasa Numune Training and Research Hospital, Uskudar, Istanbul, Turkey. 20. Department of Medical Microbiology, Faculty of Medicine, Ataturk University, Yakutiye/Erzurum, Turkey. 21. Department of Surgery, Health Sciences University, Fatih Sultan Mehmet Training and Research Hospital, Atasehir, Istanbul, Turkey.
Abstract
BACKGROUND: Gallbladder and biliary tract infections are diseases with high mortality rates if they are not treated properly. Microbiological evaluation of perioperatively collected samples both ensures proper treatment of patients and guides empirical treatment due to the determination of microorganism susceptibility. AIMS: This study aimed to isolate the microorganisms in bile cultures from patients who underwent cholecystectomy and to determine sensitivity results of these microorganisms. METHODS: This study was a multi-center and prospective design, included 360 patients, and was performed between 2019 and 2020. Culture results of bile taken during cholecystectomy were evaluated. RESULTS: Bacterial growth was found in the bile cultures of 84 out of 360 (23.3%) patients. Patients were divided into two groups according to whether they had risk factors for resistant microorganisms or not. While Escherichia coli (n = 11, 13%), Enterococcus spp. (n = 8, 9.5%), and Enterobacter spp. (n = 4, 4.7%) were detected most frequently in patients without risk. Staphylococcus spp. (n = 17, 20.2%), Enterococcus spp. (n = 16, 19%), and E. coli (n = 8, 9.5%) were the most frequently found microorganism at-risk patients. In multivariate analysis, bile culture positivity was found higher in patients who had history of biliary disease (p = 0.004), operation performed concurrently with a cholecystectomy (p = 0.035), and high rate of polymorphonuclear leukocytes (PNL) in total leukocyte count (p = 0.001). CONCLUSIONS: Our study shows that when starting empirical antibiotic treatment for bile ducts, whether patients are at risk for the development of resistant bacterial infection should be evaluated after which antibiotic selection should be made accordingly.
BACKGROUND: Gallbladder and biliary tract infections are diseases with high mortality rates if they are not treated properly. Microbiological evaluation of perioperatively collected samples both ensures proper treatment of patients and guides empirical treatment due to the determination of microorganism susceptibility. AIMS: This study aimed to isolate the microorganisms in bile cultures from patients who underwent cholecystectomy and to determine sensitivity results of these microorganisms. METHODS: This study was a multi-center and prospective design, included 360 patients, and was performed between 2019 and 2020. Culture results of bile taken during cholecystectomy were evaluated. RESULTS: Bacterial growth was found in the bile cultures of 84 out of 360 (23.3%) patients. Patients were divided into two groups according to whether they had risk factors for resistant microorganisms or not. While Escherichia coli (n = 11, 13%), Enterococcus spp. (n = 8, 9.5%), and Enterobacter spp. (n = 4, 4.7%) were detected most frequently in patients without risk. Staphylococcus spp. (n = 17, 20.2%), Enterococcus spp. (n = 16, 19%), and E. coli (n = 8, 9.5%) were the most frequently found microorganism at-risk patients. In multivariate analysis, bile culture positivity was found higher in patients who had history of biliary disease (p = 0.004), operation performed concurrently with a cholecystectomy (p = 0.035), and high rate of polymorphonuclear leukocytes (PNL) in total leukocyte count (p = 0.001). CONCLUSIONS: Our study shows that when starting empirical antibiotic treatment for bile ducts, whether patients are at risk for the development of resistant bacterial infection should be evaluated after which antibiotic selection should be made accordingly.
Authors: E Maseda; G Maggi; R Gomez-Gil; G Ruiz; R Madero; A Garcia-Perea; L Aguilar; F Gilsanz; J Rodriguez-Baño Journal: J Clin Microbiol Date: 2012-11-28 Impact factor: 5.948
Authors: Ji Won Park; Jong Kyun Lee; Kyu Taek Lee; Kwang Hyuk Lee; Young Kyung Sung; Cheol-In Kang Journal: Clin Res Hepatol Gastroenterol Date: 2014-03-24 Impact factor: 2.947
Authors: O Galili; S Eldar; I Matter; H Madi; A Brodsky; I Galis; S Eldar Journal: Eur J Clin Microbiol Infect Dis Date: 2008-03-28 Impact factor: 3.267